ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Dec. 31, 2015 |
Accounting Policies [Abstract] | |
Use of Estimates, Policy [Policy Text Block] | Use of estimates in the preparation of financial statements |
Advertising Costs, Policy [Policy Text Block] | Advertising costs – The Company expenses advertising costs as incurred. Advertising costs were $ 115,000 155,000 119,000 |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and cash equivalents – The Company considers all liquid investments with original maturities of three months or less at the date of purchase to be cash equivalents. Restricted cash is not considered a cash equivalent for purposes of the consolidated statements of cash flows. |
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] | Restricted cash |
Business Combinations And Credit Risk [Policy Text Block] | Business and credit risk All of the Company’s revenue was provided by seventeen, twenty, and nineteen customers in 2015, 2014, and, 2013, and these customers constitute accounts receivable at December 31, 2015 and 2014, respectively. The Company performs credit evaluations of its customers and generally does not require collateral. The Company has not experienced significant losses related to receivables from individual customers or groups of customers in any particular geographic area. |
Trade and Other Accounts Receivable, Policy [Policy Text Block] | Accounts receivable and doubtful accounts – Accounts receivable are recorded at net realizable value. An allowance for doubtful accounts is estimated based on historical collections plus an allowance for probable losses. Receivables are considered past due based on contractual terms and are charged off in the period that they are deemed uncollectible. Recoveries of receivables previously charged off are recorded as revenue when received. |
Non-controlling Interests [Policy Text Block] | Non-controlling interests - The Company reports its non-controlling interests as a separate component of shareholders’ equity. The Company also presents the consolidated net income and the portion of the consolidated net income and other comprehensive income allocable to the non-controlling interests and to the shareholders of the Company separately in its consolidated statements of operations and comprehensive (loss). |
Property, Plant and Equipment, Policy [Policy Text Block] | Property and equipment – Property and equipment are stated at cost less accumulated depreciation. Depreciation is determined using the straight-line method over the estimated useful lives of the assets, which for medical and office equipment is generally 3 – 10 years, and after accounting for salvage value on the equipment where indicated. Salvage value is based on the estimated fair value of the equipment at the end of its useful life. The Company capitalized interest of $ 431,000 371,000 390,000 The Company capitalizes interest incurred on property and equipment that is under construction, for which deposits or progress payments have been made. When a rate is not readily available, imputed interest is calculated using the Company’s incremental borrowing rate. The interest capitalized for property and equipment is the portion of interest cost incurred during the acquisition periods that could have been avoided if expenditures for the equipment had not been made. The Company leases Gamma Knife and radiation therapy equipment to its customers under arrangements typically accounted for as operating leases. At December 31, 2015, the Company held equipment under operating lease contracts with customers with an original cost of $ 83,267,000 47,198,000 82,151,000 46,138,000 |
Certificate Of Deposit [Policy Text Block] | Certificate of deposit – As of December 31, 2014, the Company had a $ 9,000,000 |
Investment, Policy [Policy Text Block] | Investment in equity securities – As of December 31, 2015 the Company had common stock representing an approximate 0.46 579,000 2,709,000 |
Fair Value of Financial Instruments, Policy [Policy Text Block] | – The Company’s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels. Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability. Carrying Level 1 Level 2 Level 3 Total Value December 31, 2015 Assets: Cash, cash equivalents, restricted cash $ 2,259 $ - $ - $ 2,259 $ 2,259 Investment in equity securities - - 579 579 579 Total $ 2,259 $ - $ 579 $ 2,838 $ 2,838 Liabilities Debt obligations $ - $ - $ 9,744 $ 9,744 $ 9,597 Total $ - $ - $ 9,744 $ 9,744 $ 9,597 December 31, 2014 Assets: Cash, cash equivalents, restricted cash $ 1,109 $ - $ - $ 1,109 $ 1,109 Certificate of deposit 9,000 - - 9,000 9,000 Investment in equity securities - - 330 330 2,709 Total $ 10,109 $ - $ 330 $ 10,439 $ 12,818 Liabilities Advances on line of credit $ 8,780 $ - $ - $ 8,780 $ 8,780 Debt obligations - - 10,658 * 10,658 10,591 Total $ 8,780 $ - $ 10,658 $ 19,438 $ 19,371 *Subsequent to the prior year Form 10K filing, management reviewed the inputs to fair value its debt at December 31, 2014 and determined that it misclassified these as Level 2 and the Company has correctly reclassified these as Level 3 at December 31, 2014. The disclosure reclassification adjustment is not material to previously reported consolidated financial statements. |
Revenue Recognition, Policy [Policy Text Block] | Revenue recognition - Revenue from fee per use contracts is determined by each hospital’s contracted rate. Revenue is recognized at the time the procedures are performed, based on each hospital’s contracted rate. Under revenue sharing arrangements, the Company receives a contracted percentage of the reimbursement received by the hospital. The amount the Company expects to receive is recorded as revenue and estimated based on historical experience. Under turn-key arrangements, the Company receives payment from the hospital in the amount of its reimbursement from third party payors, and the Company is responsible for paying all the operating costs of the Gamma Knife. The Company also records an estimate of net operating profit based on estimated revenues, less estimated operating costs. The gross amount the Company expects to receive from the hospital, in the amount of its reimbursement from third party payors, is recorded as revenue and estimated based on historical experience and hospital contracts with third party payors. Revenue estimates are reviewed periodically and adjusted as necessary. The operating costs of the Gamma Knife and estimated net operating profit are recorded as other direct operating costs in the consolidated statement of operations. Revenue recognition is consistent with guidelines provided under the applicable accounting standards for revenue recognition. |
Compensation Related Costs, Policy [Policy Text Block] | Stock-based compensation – The Company measures all stock-based compensation awards at fair value and records such expense in its consolidated financial statements over the requisite service period of the related award. See Note 9 for additional information on the Company’s stock-based compensation programs. |
Cost of Sales, Policy [Policy Text Block] | Costs of revenue – The Company's costs of revenue consist primarily of maintenance and supplies, depreciation and amortization, and other operating expenses (such as insurance, property taxes, sales taxes, marketing costs and operating costs from the Company’s retail sites). Costs of revenues are recognized as incurred. |
Selling, General and Administrative Expenses, Policy [Policy Text Block] | Sales and Marketing – The Company markets its services through its preferred provider status with Elekta and a direct sales effort led by its Vice President of Sales and Business Development and its Chief Operating Officer. The Company’s current business is the outsourcing of stereotactic radiosurgery services and radiation therapy services. The Company typically provides the equipment, as well as planning, installation, reimbursement and marketing support services. |
Income Tax, Policy [Policy Text Block] | Income taxes – The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. See Note 8 for further discussion on income taxes. |
Comprehensive Income (Loss), Policy [Policy Text Block] | Comprehensive (loss) – Comprehensive (loss) encompasses all changes in shareholders’ equity other than those arising from transactions with stockholders, and consists of net loss and foreign currency translation adjustments. |
Foreign Currency Transactions and Translations Policy [Policy Text Block] | Functional currency Foreign Currency Matters Gains and losses from foreign currency transactions and remeasurement are listed in the Company’s consolidated statements of operations. The net foreign currency loss was $ 0 161,000 1,174,000 |
Cumulative Translation Adjustment [Policy Text Block] | Cumulative translation adjustment Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries of Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity a financial interest in EWRS Turkey. As such, the cumulative translation adjustments previously recognized under accumulated other comprehensive (loss) were released into net income as a component of the loss for the sale of EWRS Turkey in the statement of operations. 779,000 |
Discontinued Operations, Policy [Policy Text Block] | Discontinued Operations Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity Effective May 31, 2014 (with closing occurring June 10, 2014) the Company sold EWRS Turkey for EUR 4.2 6.0 768,000 572,000 |
Earnings Per Share, Policy [Policy Text Block] | Earnings per share – Basic earnings per share excludes dilution and is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the year. The fully vested restricted stock units not issued and outstanding, are also included therein. Diluted earnings per share reflect the potential dilution that could occur if common shares were issued pursuant to the exercise of options or warrants. 2015 2014 2013 Numerator for basic and diluted (loss) earnings per share $ (1,522,000) $ (952,000) $ (312,000) Denominator: Denominator for basic and diluted (loss) earnings per share – weighted-average shares 5,519,000 5,028,000 4,608,000 (Loss) earnings per common share – basic and diluted $ (0.28) $ (0.19) $ (0.07) In 2015, options outstanding to purchase 614,000 2.05 3.15 200,000 2.20 In 2014, options outstanding to purchase 633,000 2.43 6.16 200,000 2.20 In 2013, options outstanding to purchase 576,000 2.30 6.50 |
Segment Reporting, Policy [Policy Text Block] | Business segment information - Based on the guidance provided in accordance with ASC 280 Segment Reporting The Company did not have any international operations as of December 31, 2015, but the Company’s unit in Peru is expected to being operations in 2016 and is reflected in the property and equipment table below for 2015. 2015 2014 2013 Medical services revenues Domestic 100 % 97 % 91 % Foreign 0 % 3 % 9 % Total 100 % 100 % 100 % 2015 2014 2013 Property and equipment, net Domestic 93 % 94 % 84 % Foreign 7 % 6 % 16 % Total 100 % 100 % 100 % |
Nonmonetary transactions [Policy Text Block] | Nonmonetary transactions – Based on guidance provided in accordance with ASC No. 845 Nonmonetary Transactions 700,000 |
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] | Long lived asset impairment – The Company assesses the recoverability of its long-lived assets when events or changes in circumstances indicate their carrying value may not be recoverable. Such events or changes in circumstances may include: a significant adverse change in the extent or manner in which a long-lived asset is being used, significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset, an accumulation of costs significantly in excess of the amount originally expected for the acquisition or development of a long-lived asset, current or future operating or cash flow losses that demonstrate continuing losses associated with the use of a long-lived asset, or a current expectation that, more likely than not, a long-lived asset will be sold or otherwise disposed of significantly before the end of its previously estimated useful life. The Company performs impairment testing at the asset group level that represents the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. The Company assesses recoverability of a long-lived asset by determining whether the carrying value of the asset group can be recovered through projected undiscounted cash flows over their remaining lives. If the carrying value of the asset group exceeds the forecasted undiscounted cash flows, an impairment loss is recognized, measured as the amount by which the carrying amount exceeds estimated fair value. An impairment loss is charged to the consolidated statement of operations in the period in which management determines such impairment. No such impairment has been noted as of December 31, 2015 and 2014. |
Reclassification, Policy [Policy Text Block] | Out-of-Period Adjustment: During the fourth quarter of 2014, the Company reclassified $ 400,000 235,000 |
New Accounting Pronouncements, Policy [Policy Text Block] | Recently issued accounting pronouncements – In January 2015, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2015-01, Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items In February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis In April 2015, the FASB issued ASU No. 2015-03, Interest Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs In November 2015, the FASB issued ASU No. 2015-17 Income Taxes - Balance Sheet Classification of Deferred Taxes 367,000 In January 2016, the FASB issued ASU No. 2016-01 Recognition and Measurement of Financial Assets and Financial Liabilities In February 2016, the FASB issued ASU No. 2016-02 Leases In August 2014, the Financial Accounting Standards Board “(FASB”) issued ASU 2014-15, Disclosure of Uncertainties About an Entity’s Ability to Continue as a Going Concern In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers |